Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies

Similar pages

• Trial
  A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer

  Shares ImmuNext, CI-8993, Curis, Johnson & Johnson and the tag pipeline.

• Trial
  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

  Shares Johnson & Johnson, Metastatic cancer (cancer that has spread) and the tag pipeline.

• Trial
  A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

  Shares Curis and the tag pipeline.

• Trial
  CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  Shares Curis and the tag pipeline.

• Trial
  Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer

  Shares Metastatic cancer (cancer that has spread) and the tag pipeline.

• Trial
  Plasmodium Immunotherapy for Advanced Malignant Solid Tumors

  Shares Metastatic cancer (cancer that has spread) and the tag pipeline.

• Trial
  Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors

  Shares Metastatic cancer (cancer that has spread) and the tag pipeline.

• Trial
  A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

  Shares Metastatic cancer (cancer that has spread) and the tag pipeline.